Technical Analysis for WAVE - Waverly Pharma Inc.

Grade Last Price % Change Price Change
D 0.035 0.00% 0.000
WAVE closed up 40.0 percent on Wednesday, April 17, 2024, on 1.12 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Weak + Overbought Other 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Waverley Pharma Inc is a Canada-based company engaged in Biotechnology & Medical Research sector.The Company is focused on developing and commercializing Safe and Effective Small Molecules for Treatment of Cancer. Waverley Pharma is working in collaboration with a Indian conglomerate based in Mumbai to develop products for the treatment of cancer. Two of the lead products under developments are: WAV-101: WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications; WAV-102 is also an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. The Company has signed an agreement with Omgene Life Sciences for the development of another generic anti-cancer product WAV-103.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Occupational Safety And Health Medicine Pharma Drug Labor Biotechnology Science Cancer Life Sciences Therapy Collaboration Oncology Drug Development Lung Cancer Treatment Of Cancer Chemotherapy Non Small Cell Lung Cancer Multiple Myeloma Treatment Of Non Small Cell Lung Cancer

Is WAVE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.14
52 Week Low 0.015
Average Volume 16,999
200-Day Moving Average 0.064
50-Day Moving Average 0.028
20-Day Moving Average 0.025
10-Day Moving Average 0.028
Average True Range 0.007
RSI (14) 55.36
ADX 12.22
+DI 36.976
-DI 30.022
Chandelier Exit (Long, 3 ATRs) 0.016
Chandelier Exit (Short, 3 ATRs) 0.035
Upper Bollinger Bands 0.036
Lower Bollinger Band 0.013
Percent B (%b) 0.94
BandWidth 96.327
MACD Line 0.001
MACD Signal Line -0.001
MACD Histogram 0.0015
Fundamentals Value
Market Cap 1.89 Million
Num Shares 54 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -2.19
Price-to-Sales 6.91
Price-to-Book 3.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.058
Resistance 3 (R3) 0.055 0.045 0.054
Resistance 2 (R2) 0.045 0.039 0.046 0.052
Resistance 1 (R1) 0.040 0.036 0.043 0.043 0.051
Pivot Point 0.030 0.030 0.031 0.031 0.030
Support 1 (S1) 0.025 0.024 0.028 0.028 0.019
Support 2 (S2) 0.015 0.021 0.016 0.018
Support 3 (S3) 0.010 0.015 0.016
Support 4 (S4) 0.013